Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapy
Not available.
Saved in:
| Main Authors: | Francesca Sillito, Alexandros Rampotas, Kathleen Cheok, Sabine Pomplun, Robert Baker, Teresa Marafioti, Maeve O'Reilly, Rajeev Gupta, Amy A. Kirkwood, Claire Roddie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-04-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12049 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD19‐targeting chimeric antigen receptor T‐cell therapy is safe and effective for intra‐cardiac B cell non‐Hodgkin lymphoma
by: Daniel H. Chen, et al.
Published: (2024-12-01) -
Clonal Hematopoiesis, a Risk Condition for Developing Myeloid Neoplasia
by: Ugo Testa, et al.
Published: (2025-04-01) -
Recent advances of chimeric antigen receptor T‐cell therapy for acute myeloid leukemia
by: Yang Liu, et al.
Published: (2025-05-01) -
Advancing Chimeric Antigen Receptor T-Cell Therapy for Acute Myeloid Leukemia: Current Limitations and Emerging Strategies
by: Daniela Damiani, et al.
Published: (2024-12-01) -
Clonal hematopoiesis and acute myeloid leukemia
by: A. I. Kashlakova, et al.
Published: (2023-09-01)